APC.H — Advanced Proteome Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
FinancialsHighly SpeculativeMicro Cap
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.893 | -0.461 | -0.541 | -1.92 | 0.597 |
Depreciation | |||||
Non-Cash Items | -0.194 | -0.39 | 0.001 | 1.39 | -1.57 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.131 | 0.161 | 0.07 | -0.013 | 0.278 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -1.21 | -0.686 | -0.467 | -0.545 | -0.694 |
Capital Expenditures | — | -0.001 | 0 | -0.002 | -0.014 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | -0.048 | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | -0.001 | 0 | -0.05 | -0.014 |
Financing Cash Flow Items | — | — | — | — | 0.279 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.21 | 0.683 | 0.337 | 1.42 | 0.429 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.002 | -0.004 | -0.13 | 0.82 | -0.278 |